Abstract
Designing studies such that they have a high level of power to detect an effect or association of interest is an important tool to improve the quality and reproducibility of findings from such studies. Since resources (research subjects, time, and money) are scarce, it is important to obtain sufficient power with minimum use of such resources. For commonly used randomized trials of the treatment effect on a continuous outcome, designs are presented that minimize the number of subjects or the amount of research budget when aiming for a desired power level. This concerns the optimal allocation of subjects to treatments and, in case of nested designs such as cluster-randomized trials and multicenter trials, also the optimal number of centers versus the number of persons per center. Since such optimal designs require knowledge of parameters of the analysis model that are not known in the design stage, in particular outcome variances, maximin designs are presented. These designs guarantee a prespecified power level for plausible ranges of the unknown parameters and minimize research costs for the worst-case values of these parameters. The focus is on a 2-group parallel design, the AB/BA crossover design, and cluster-randomized and multicenter trials with a continuous outcome. How to calculate sample sizes for maximin designs is illustrated for examples from nutrition. Several computer programs that are helpful in calculating sample sizes for optimal and maximin designs are discussed as well as some results on optimal designs for other types of outcomes.
Original language | English |
---|---|
Pages (from-to) | 1063-1085 |
Number of pages | 23 |
Journal | American Journal of Clinical Nutrition |
Volume | 117 |
Issue number | 6 |
Early online date | 1 Jun 2023 |
DOIs | |
Publication status | Published - 1 Jun 2023 |
Keywords
- cluster-randomized trial
- crossover design
- efficient trial
- maximin design
- multicenter trial
- optimum design
- parallel group design
- power
- repeated measures
- sample size calculation
- CLUSTER RANDOMIZED-TRIALS
- STEPPED-WEDGE TRIALS
- CLINICAL-TRIALS
- STATISTICAL POWER
- TREATMENT ALLOCATION
- FOLLOW-UP
- INTRACLASS CORRELATION
- TIME INTERACTION
- DOUBLE-BLIND
- WEIGHT-LOSS